Fig. 8
From: Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation
Pharmacodynamic studies (A) Photographic recordings of rat corneas with alkali burns on days 3, 7, and 14 (B) Rat corneal alkali burn scores (n = 6) (C) H&E staining of rat corneas (D) Immunofluorescence staining of rat corneas with VEGFA (E) PCR results (n = 6); Data are presented as the mean ± SD *p < 0.05, **p < 0.01, ***p < 0.001